Vitamin D and infectious diseases;Vitamine D et infections

Presse Medicale

Volumn 42, Issue 10, 2013, Pages 1371-1376

  Ghosn, Jade ^a,b   Viard, Jean Paul ^a,b  

^a HÔTEL DIEU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPEPTIDE ANTIBIOTIC AGENT; VITAMIN D;

AUTOPHAGY; DISEASE ASSOCIATION; DISEASE SEVERITY; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; LUNG TUBERCULOSIS; SHORT SURVEY; TREATMENT RESPONSE; VITAMIN SUPPLEMENTATION;

ANTIBODY FORMATION; CHRONIC DISEASE; COMMUNICABLE DISEASES; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VACCINATION; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84886284697     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2013.07.009     Document Type: Short Survey

References (28)

1. Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011, 7:337-345.
2. Herrting O., Holm A., Lüthje P., Brauner H., Dyrdak R., Jonasson A.F., et al. Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS One 2010, 5(12):e15580.
3. Campbell G.R., Spector S.A. Toll-like receptor 8ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1. PLoS Pathog 2012, 8(11):e1003017.
4. Pace L., Tempez A., Arnold-Schrauf C., Lemaitre F., Bousso P., Felter L., et al. Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. Science 2012, 338(6106):532-536.
5. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008, 168:1340-1349.
6. Schleithoff S.S., Zittermann A., Tenderich G., Berthold H.K., Stehle P., Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled study. Am J Clin Nutr 2006, 83:754-759.
7. Hyppönen E., Berry D., Cortina-Borja M., Power C. 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958British birth cohort. PLoS One 2010, 5(5):e10801.
8. Kuller L.H., Tracy R., Belloso W., De Witt S., Dumond F., Lane H.C., et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008, 5(10):e203.
9. Ralph A.R., Lucas R.M., Norval M. Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis. Lancet Infect Dis 2013, 13:77-88.
10. Gibney K.B., MacGregor L., Leder K., Torresi J., Marshall C., Ebeling P.R., et al. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin Infect Dis 2008, 46:443-446.
11. Martineau A.R., Nhamoyebonde S., Oni T., Rangaka M.X., Marais S., Bangani N., et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci U S A 2011, 108:19013-19017.
12. Martineau A.R., Honecker F.U., Wilkinson R.J., Griffiths C.J. Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 2007, 103:793-798.
13. Martineau A.R., Timms P.M., Bothamley G.H., Hanifa Y., Islam K., Claxton A.P., et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011, 377:242-250.
14. Ginde A.A., Mansbach J.M., Camargo C.A. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009, 169:384-390.
15. Murdoch D.R., Slow S., Chambers S.T., Jennings L.C., Stewart A.W., Priest P.C., et al. Effect of vitamin D3supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA 2012, 308:1333-1339.
16. Lehouck A., Mathieu C., Carremans C., Baeke F., Verhaegen J., Van Eldere J., et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2012, 156:105-114.
17. Manaseki-Holland S., Maroof Z., Bruce J., Mughal M.Z., Masher M.I., Bhutta Z.A., et al. Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet 2012, 379:1419-1427.
18. Mehta S., Hunter D.J., Mugusi F.M., Spiegelman D., Manji K.P., Giovanucci E.L., et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 2009, 200:1022-1030.
19. Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP et al. Associations between 25-Hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons. The ANRS CO9 «COPANA» cohort study. PLoS ONE (sous presse).
20. Viard J.P., Souberbielle J.C., Kirk O., Knysz B., Losso M., Gatell J., et al. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 2011, 25:1305-1315.
21. Sudfeld C.R., Giovannucci E.L., Isanaka S., Aboud S., Mugusi F.M., Wang M., et al. Vitamin D status and incidence of pulmonary tuberculosis, opportunistic infections and wasting among HIV-infected Tanzanian adults initiating antiretroviral therapy. J Infect Dis 2013, 207:378-385.
22. Vescini F., Cozzi-Lepri Borderi M., Re M.C., Maggiolo F., De Luca A., Cassola G., et al. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J Acquir Immune Defic Syndr 2011, 58:163-172.
23. Petta S., Cammà C., Scazzone C., Tripodo C., Di Marco V., Bono A., et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1chronic hepatitis C. Hepatology 2010, 51:1158-1167.
24. Mandorfer M., Reiberger T., Payer B.A., Ferlitsch A., Breitenecker F., Aichelburg M.C., et al. Low vitamin D levels are associated with impaired virologic response to PEGIFN+RBV therapy in HIV-hepatitis C virus coinfected patients. AIDS 2013, 27:227-232.
25. Abu-Mouch S., Fireman Z., Jarchovsky J., Zeina A.R., Assy N. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients. World J Gastroenterol 2011, 17:5184-5190.
26. Zitt E., Sprenger-Mähra H., Knoll F., Neyer U., Lhotta K. Vitamin D deficiency is associated with poor response to active hepatitis B immunisation in patients with chronic kidney disease. Vaccine 2012, 30:931-935.
27. Heine G., Drosdenko G., Lahl A., Unterwalder N., Mei H., Volk H.D., et al. Efficient tetanus toxoid immunization on vitamin D supplementation. Eur J Clin Nutr 2011, 65:329-334.
28. Momplaisir F., Frank I., Meyer W.A., Kim D., Kappes R., Tebas P. Vitamin D levels, natural H1N1infection and response to H1N1vaccine among HIV-infected individuals. J AIDS Clin Res 2012, 3:152.